Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Proov logo — Proov offers OTC at-home testing, including the only FDA cle...

Proov

Proov offers OTC at-home testing, including the only FDA cleared at-home test to confirm successful ovulation via PdG.

Founded 2016 United States Erie, United States 22 employees Series A Total: $9.96M Biotechnology, Health Care +3

General Information

Company Name Proov
Founded Year 2016
Location United States Erie, United States +1
Employees 22
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Series A
Social

Get notified when Proov moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Proov

Proov is a biotechnology and healthcare startup based in the United States that offers OTC at-home testing, including the only FDA cleared at-home test to confirm successful ovulation via PdG. The company, founded in 2018 by Amy Beckley, Ph.D, provides a suite of diagnostics to offer fertility insights throughout the entire menstrual cycle. Proov's offering includes easy, at-home urine tests that, when paired with the free Proov Insight app, provide a science-backed fertility coach right in the user's hand. Users can measure all menstrual hormones daily with Proov tests, then utilize the app to understand ovulation status, receive daily insights, and an Ovulation Insights score. The app then generates a personalized action plan to maximize wellness or develop a fertility strategy. The company recently secured a $9.70M Series A investment on 15 December 2021, with participation from a consortium of investors including GingerBread Capital, Lightship Capital, SteelSky Ventures, Portfolia, WCC Partners, Hambrecht Ducera Growth Ventures, and Kim Perell. Proov's focus on tracking pregnanediol glucuronide (PdG), a metabolite of progesterone, positions it as a leader in understanding hormone health. With a compelling backstory that underlines the founder's personal connection to the product, Proov stands as an innovative player in the fertility diagnostics space.

Taxonomy: at-home testing, fertility diagnostics, ovulation tracking, hormone health, women's health, infertility, PdG testing, fertility app, Venture capital-backed, pregnancy support, progesterone testing, female entrepreneurship, startups, healthtech

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 7
Investor Investor Investor Investor
•••• •••• 		15 Dec 2021
Grant •••••• 1
Investor
09 Feb 2021
Seed Round •••••• 2
Investor Investor
09 Sep 2020
Non Equity Assistance •••••• - 26 Sep 2019
Seed Round •••••• - 08 Aug 2018

FAQ About Proov

Proov offers OTC at-home testing, including the only FDA cleared at-home test to confirm successful ovulation via PdG.
Proov was founded in 2016.
Proov is headquartered in Erie, United States.
Proov operates in the following industries: Biotechnology, Health Care, Health and Wellness, Medical Devices, Women's Health.
Proov has approximately 22 employees.
Proov has completed 5 funding rounds, raising a total of $9.96M. The latest funding stage is Series A.

We're actively collecting intelligence on Proov.

Track Proov to get notified

Don't just browse. Track.

Signal Tracker monitors Proov and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy